Latest / This Week In Medicine
Best of JAMA 2025: Episode 6:Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
This research study investigates a potential link between popular metabolic medications and a serious vision-threatening condition known as neovascular age-related macular degeneration. By analyzing a massive database of elderly patients with diabetes, scientists discovered that those who used GLP-1 receptor agonists for at least six months faced double the risk of developing this specific eye disease compared to those not taking the drugs. The findings highlight a critical need for clinicians to weigh the systemic benefits of these treatments against possible long-term ocular complications…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.